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Introduction {#sec1}
============

Pluripotent stem cells hold significant therapeutic potential in the context of degenerative disease. To use pluripotent cells in transplantation therapies, a thorough understanding of the molecular mechanisms that regulate immortality through self-renewal becomes a key requirement. The specialized cells that arise from pluripotent cells during development do so through temporal restrictions in their cellular plasticity. The blueprint behind this cell-fate determination is the transcriptome, whose status is based upon regulatory networks consisting of epigenetic machinery, transcription factors, and noncoding RNAs (ncRNAs).

Although well studied, protein-coding sequences account for only approximately 2% of the genome and 28%--40% of the transcriptome in humans ([@bib3], [@bib26]). This suggests that non-protein-coding RNAs may have heretofore unidentified functions. Indeed, it has been demonstrated that ncRNAs are abundant regulatory components of vertebrate transcriptomes. This is particularly evident for long noncoding RNAs (lncRNAs; \>200 nt long) and the noncoding class of small RNAs termed microRNAs (miRNAs), which influence numerous biological processes including proliferation, apoptosis, and differentiation.

Mechanistically, lncRNAs have emerged as multifaceted regulators of various cellular processes, with roles that include influencing epigenetic landscapes, transcriptional circuitry, and post-transcriptional regulatory processes ([@bib59], [@bib71]). While lncRNAs generally have no significant open reading frame, many share characteristics of mRNAs such as 5′ capping, splicing, and polyadenylation ([@bib8], [@bib22]). Typically, tissue-specific expression of lncRNAs is more demarcated than that of mRNAs, and it follows that several lncRNAs have been implicated in organ development and cell-fate specification ([@bib21]). These data point to the need for the elucidation of lncRNA function in both specialized and unspecialized cell types.

To date, thousands of lncRNAs have been identified through transcriptomics, particularly RNA sequencing (RNA-seq), in embryonic stem cells (ESCs) ([@bib8], [@bib22]), yet well-defined biological functions are known for very few. However, loss-of-function approaches can provide insight into roles for lncRNAs in the maintenance of self-renewal and pluripotency, reprogramming, and differentiation ([@bib23], [@bib33], [@bib36], [@bib45], [@bib46]). Such functional characterization would address precise roles for individual lncRNAs in pluripotent stem cell maintenance.

*Cyrano* (*linc-oip5*, *1700020I14Rik*) is a long intergenic ncRNA (lincRNA) transcribed in mouse ESCs ([@bib12], [@bib22], [@bib70]) that was first characterized in zebrafish ([@bib70]). In zebrafish, it is a key regulator that functions in brain, eye, and nasal development ([@bib70]). This is at least in part mediated by a short region of high sequence conservation among vertebrate genomes that is critical for function. Rescue experiments in zebrafish utilizing higher-order orthologs provided the first insight that *Cyrano* may have a functional role in mice ([@bib70]).

miRNAs, which are much shorter ncRNAs (approximately 22 nt), have also been assigned regulatory roles in numerous biological processes. Historically, miRNAs have been thought to function through pairing with complementary sequences in the 3′ UTR of target mRNAs to repress gene expression at the post-transcriptional level ([@bib5]). More recently, broader miRNA functionality has been recognized. This includes noncanonical binding to non-3′ UTR regions including the coding sequence of target genes, as well as cross-regulatory interactions that exist between miRNAs and lncRNAs to affect either miRNA or lncRNA stability and/or function, and the regulation of downstream targets ([@bib29], [@bib55]).

One such lncRNA/miRNA interaction has been postulated between *Cyrano* and *mir-7* ([@bib70]). At the cellular level, *mir-7* is associated with differentiation ([@bib16], [@bib39], [@bib54]), with its levels increasing during neural specification from neural stem cells ([@bib16]). In various cellular contexts, it acts by inhibiting receptor-mediated signaling pathways, including EGFR and STAT3 signaling, to promote differentiation and modulate cellular adhesion ([@bib32], [@bib54], [@bib68], [@bib82]). Antagonism of *mir-7* function, mediated by sequestration and inactivation via molecular sponges or decoy RNAs, is a well-known strategy for moderating its activity on target transcripts. One of the best-studied examples is the circular RNA *CD1Ras*/*CiRS-7*, which possesses multiple seed matches to *miR-7* ([@bib24], [@bib48]). Sponge-based regulation of miRNA activity is also employed in the ESC regulatory landscape to prevent post-transcriptional degradation of key pluripotency factors including *Oct4*, *Sox2*, and *Nanog* ([@bib72]).

Here, we demonstrate that *Cyrano* is essential for maintenance of self-renewing ESCs. Our studies revealed that interplay between *Cyrano* and *mir-7* affects key properties including cell adhesion in colony maintenance to support ESC immortality. Importantly, *Cyrano* depletion disrupts self-renewal signaling and gene expression regulatory networks, particularly the expression of *Nanog*. Aberrations in these properties including the loss of *Nanog* expression, cell adhesion, and colony survival to maintain self-renewal capacity are recapitulated in *mir-7* gain-of-function experiments. This supports the existence of a competing relationship between *mir-7* and *Cyrano* in ESCs.

Results {#sec2}
=======

lncRNA *Cyrano* Exhibits Stability and Is Broadly Localized in ESCs {#sec2.1}
-------------------------------------------------------------------

While lncRNAs exhibit a range of localization patterns ([@bib9]), their basic localization provides preliminary insight into their cellular functions. For instance, nuclear-domain localized lncRNAs, including *Xist* and *Kcnq1ot1*, function to silence vast chromatin domains, while the cytoplasmic lncRNA *H19* is a primary miRNA precursor ([@bib10], [@bib34]).

To characterize the function of *Cyrano* in ESCs, we first used single-molecule fluorescence in situ hybridization (smFISH) and fractionation methods to examine *Cyrano*\'s subcellular localization. Through z-stack imaging of multiple ESC lines, smFISH revealed distinct signals in the nucleus and cytoplasm throughout ESC colonies ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A--S1D), averaging ∼40 molecules per cell ([Figure 1](#fig1){ref-type="fig"}B). This distribution was confirmed by subcellular fractionation comparing the localization of spliced *Cyrano* to the unspliced nuclear form, cytoplasmic *H19* ([@bib34]) and nuclear speckle-localized *Malat1* ([@bib50]) ([Figure 1](#fig1){ref-type="fig"}C). Furthermore, ENCODE data from human ESCs ([@bib20], [@bib80]) showed similar subcellular localization of the unspliced and spliced human ortholog, *OIP5-AS1* ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Consistent with the lack of enrichment in either cellular compartment ([@bib15], [@bib67]), we found that *Cyrano* displayed moderate stability of t~1/2~ ∼6 hr in ESCs ([Figure 1](#fig1){ref-type="fig"}D). *Cyrano*\'s distribution in the cell could indicate that nuclear and cytoplasmic *Cyrano* pools have distinct functions or that it interacts with proteins that shuttle from the nucleus to the cytoplasm.Figure 1*Cyrano* Displays Dispersed Subcellular Localization and Exhibits Stability in ESCs(A) smFISH analysis of a representative ESC colony shows *Cyrano* localization in the nucleus and cytoplasm of ESCs. Nuclei, blue (DAPI). Scale bar, 10 μm.(B) Quantitation of *Cyrano* molecules/ESC.(C) Subcellular fractionation and qRT-PCR confirms *Cyrano*\'s presence in the nucleus and cytoplasm.(D) Assessment of the stability of *Cyrano*.Data are from three independent experiments. Error bars represent SEM. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

*Cyrano* Is Required for Maintenance of ESC Self-Renewal {#sec2.2}
--------------------------------------------------------

In addition to consistent localization and expression among ESC lines, microarray analysis of early embryonic developmental stages ([@bib77]) revealed an increase in *Cyrano* expression in morulae and blastocysts relative to two well-studied lncRNAs, *H19* and *Airn* ([Figure 2](#fig2){ref-type="fig"}A). Similar results were obtained upon examination of single-cell RNA-seq data ([@bib17]) from ESCs ([Figure S2](#mmc1){ref-type="supplementary-material"}A). ESCs are derived from blastocysts and are an excellent model system for early developmental processes.Figure 2*Cyrano* Deficiency Impairs ESC Self-Renewal(A) Expression analysis (GEO: [GSE18290](ncbi-geo:GSE18290){#intref0040}) of *Cyrano*, *Airn*, and *H19* lncRNAs in early development.(B) qRT-PCR shows significant reduction in *Cyrano* expression upon KD using independent shRNAs, compared with a nontargeting control. Experiments were performed in triplicate, normalized to *GAPDH*, with error bars representing 95% CI.(C) *Cyrano* KD results in loss of the ESC characteristic colony morphology. Scale bar, 100 μm.(D) KD of *Cyrano* results in a decrease in cell numbers as determined by cell counts beginning with plating on day 1 post transfection.(E and F) Significant reduction in alkaline phosphatase staining of ESC colonies after *Cyrano* KD. n \> 200. Scale bar, 100 μm.(G) Increases in cell death observed upon *Cyrano* KD 2 days post transfection. Nuclei (blue, live; green, dead). Scale bar, 200 μm.Counts were performed in triplicate with error bars representing SD. Data are from three independent experiments. ^∗∗^p \< 0.01. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

We used short hairpin RNA (shRNA) knockdown (KD) to examine the effect of loss of *Cyrano* expression in ESCs. Independent shRNAs reproducibly achieved greater than 60%--85% reduction of *Cyrano* levels ([Figures 2](#fig2){ref-type="fig"}B, [S2](#mmc1){ref-type="supplementary-material"}B, and S2C) compared with a nontargeting control (NTC). Within 2--3 days of expression of shRNAs, we found that *Cyrano*-depleted cells were unable to robustly maintain a typical ESC phenotype of tightly packed cells assembled in a dome-shaped colony in leukemia inhibitory factor (LIF)-containing ESC medium ([Figure 2](#fig2){ref-type="fig"}C). Because of possible shortcomings in KD efficiency due to multiple lncRNA splice variants, differential subcellular localization, and possible nontargeting of shRNAs, the loss-of-self-renewal phenotype was confirmed using additional shRNAs ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D) and in an independent ESC line ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Specifically, we observed increased numbers of cells floating in the medium and prominent partitioning of cell-cell contacts. This is unlike the standard pluripotent ESC state in which cell-cell boundaries within a colony are difficult to define. Along with this breakdown in the colony maintenance of self-renewing ESCs, we observed a sharp reduction in cell numbers in *Cyrano*-depleted cells ([Figure 2](#fig2){ref-type="fig"}D). Loss of self-renewal was further underscored by a qualitative and quantitative loss of alkaline phosphatase activity ([Figures 2](#fig2){ref-type="fig"}E, 2F, [S2](#mmc1){ref-type="supplementary-material"}D, and S2E) and increases in cell death ([Figure 2](#fig2){ref-type="fig"}G). Altogether, these data indicate that *Cyrano* is required for maintenance of ESC self-renewal.

The ESC Gene Expression Signature Is Disrupted by *Cyrano* Deficiency {#sec2.3}
---------------------------------------------------------------------

Pluripotent ESCs are characterized by a well-documented gene expression profile that supports their ability to self-renew while maintaining the capacity for differentiation into embryonic germ layer derivatives ([@bib7]). We next examined modifications in gene expression profiles upon *Cyrano* KD to determine whether cells assumed a particular cellular identity upon *Cyrano* loss. Total read number in RNA-seq experiments for samples ranged from 23 to 29 million reads, with mapped reads ranging from 88% to 90% of total read number. Concomitant with morphological anomalies, RNA-seq uncovered significant differential gene expression due to shRNA-mediated KD ([Figure 3](#fig3){ref-type="fig"}A). Sample comparisons revealed 489 and 380 up- and downregulated genes, respectively, between control and KD samples ([Figure 3](#fig3){ref-type="fig"}A). Validation of differentially expressed non-pluripotency-related genes was carried out by qRT-PCR ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Ingenuity Pathway Analysis (IPA) classification revealed that the top dysregulated pathways post KD were primarily related to cell adhesion, signaling, and motility ([Figure 3](#fig3){ref-type="fig"}B), observations consistent with the loss-of-function phenotype. Based on these results and phenotypic observations ([Figure 2](#fig2){ref-type="fig"}C), we further assessed anomalies in cell adhesion by examining localization of E-cadherin ([Figure 3](#fig3){ref-type="fig"}C) and F-actin ([Figure S3](#mmc1){ref-type="supplementary-material"}B) in immunofluorescence assays. E-cadherin is a key pluripotency cell-signaling modulator ([@bib58]) that typically mediates cell-cell adhesion and is normally found at cell-cell boundaries in ESC colonies. We observed aberrant localization of cell membranous E-cadherin on *Cyrano* depletion ([Figure 3](#fig3){ref-type="fig"}C). Furthermore, phalloidin staining ([Figure S3](#mmc1){ref-type="supplementary-material"}B) revealed a loss of F-actin localization as is typically seen at the cell cortex in ESCs ([@bib63]). In addition to anomalous cell and colony morphology, this uncharacteristic localization of qualitative markers, whose localization is normally indicative of self-renewing ESC colonies, further indicates atypical cell adhesion in colony maintenance.Figure 3*Cyrano* Depletion Results in Aberrant Gene Expression in ESCs(A) Smear plot comparing gene expression in NTC and KD samples reveals significant gene expression changes 3 days post KD. Differentially expressed genes are indicated in red, compared with insignificant genes in black (FDR \< 0.05).(B) IPA analysis of differentially expressed genes shows an enrichment of pathways after *Cyrano* KD.(C) Immunofluorescence examination of E-cadherin in control and KD cells, showing aberrant localization. Nuclei, blue (DAPI); Scale bar, 100 μm.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

*Cyrano* Depletion Disrupts *Nanog* Expression {#sec2.4}
----------------------------------------------

We next rank-ordered genes that showed a decrease in expression (false discovery rate \[FDR\] \< 0.05). As expected, the reduction in *Cyrano* expression was most significant using this threshold ([Figure 4](#fig4){ref-type="fig"}A). Interestingly, the master pluripotency regulator *Nanog* was one of the more significantly downregulated genes ([Figure 4](#fig4){ref-type="fig"}A). Further examination of expression of other key factors in self-renewal maintenance ([@bib78]) including *Oct4*, revealed that they remained mostly unchanged while there was a decrease in *Nanog* levels ([Figures 4](#fig4){ref-type="fig"}B, [S4](#mmc1){ref-type="supplementary-material"}A--S4D). The specific downregulation of *Nanog* and not other master regulators, including *Oct4*, suggests that *Cyrano* affects a specific subset of self-renewal master genes to result in the observed phenotype, as opposed to being an indirect result of spontaneous differentiation.Figure 4Depletion of *Cyrano* Results in Altered Expression of *Nanog* and Lineage-Related Genes(A) Ranking of the top-10 decreased genes in RNA-seq based on FDR (black bars) shows significant decreases in *Nanog* levels with *Cyrano* KD. Fold change is also indicated (white bars).(B) Assessment of pluripotency regulators on *Cyrano* KD reveals that *Nanog* displays the most significant differential regulation.(C--J) UCSC genome browser plots shows RNA-seq reads mapped to mm9 and normalized to remove sequencing depth biases, and independent qRT-PCR examination upon *Cyrano* KD indicates increased expression of factors that antagonize self-renewal in mouse ESCs. Data are from three independent experiments with error bars representing 95% CI. ^∗^p \< 0.05, ^∗∗^p \< 0.01.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Aberrant Expression of Anti-Self-Renewal Factors Is Associated with *Cyrano* Depletion {#sec2.5}
--------------------------------------------------------------------------------------

The phenotype upon *Cyrano* loss led us to more closely examine genes that showed significant increases in expression. This revealed key anti-pluripotency genes, including developmental regulators not associated with the ESC state. These include lineage specification markers (*Otx2*, *Nestin*, *Gata4*, *Pdgfra*, and *Sox11*; [Figures 4](#fig4){ref-type="fig"}C--4G) and the epithelial-mesenchymal transition factor, *Snai1* ([Figure 4](#fig4){ref-type="fig"}H). Furthermore, we observed increases in *Apela* expression ([Figure 4](#fig4){ref-type="fig"}I), a recently described regulatory RNA with the ability to encode a small peptide hormone ([@bib13], [@bib43], [@bib56]). The upregulation of *Apela* is consistent with it being a genomic target of *Nanog*, whose expression increases upon RNAi-mediated depletion of *Nanog* ([@bib47]), and its role in mesendoderm specification in zebrafish ([@bib13]). *Apela* expression abruptly increases upon LIF withdrawal in mouse ESCs ([Figure S4](#mmc1){ref-type="supplementary-material"}E), consistent with the reduced capacity to differentiate into mesoderm and endoderm in embryoid bodies with *Apela* depletion ([@bib43]). As *Apela* has been recently shown to be important for self-renewal maintenance in human ESCs ([@bib27]), the rapid upregulation may represent a transition from naive to primed pluripotency prior to spontaneous differentiation. Consistent with this, subsequent downregulation of *Apela* is seen later in mouse ESC differentiation ([Figure S4](#mmc1){ref-type="supplementary-material"}E), similar to the decrease observed in human ESC differentiation ([@bib13]). These results suggest that deviations from ideal *Apela* levels antagonize maintenance of the ESC state.

The constitutive cell cycle of ESCs, which lacks the periodicity of differentiated cell types, is associated with a lack of cyclin D regulation ([@bib74]). Consistent with the phenotypic change and decreased proliferative capacity, we observed an increase in levels of the cyclin D-Cdk inhibitor, *Cdkn2a*, in *Cyrano*-deficient cells relative to controls ([Figure 4](#fig4){ref-type="fig"}J).

Taken together, these gene expression alterations support the failure to retain self-renewal capacity upon *Cyrano* depletion. The function of *Cyrano* does not appear to primarily be via proximal *cis* mechanisms, as no significant gene expression changes were observed in RNA-seq (FDR \< 0.05) for neighboring genes within a 100-kb window ([Figure S4](#mmc1){ref-type="supplementary-material"}F), and consistent changes were not observed for both shRNAs in qRT-PCR analyses ([Figure S4](#mmc1){ref-type="supplementary-material"}G).

*Cyrano* Counteracts *mir-7* Action in ESCs to Support Self-Renewal Maintenance {#sec2.6}
-------------------------------------------------------------------------------

We sought to determine how *Cyrano* mediates these survival, adhesion, and anti-differentiation roles in ESCs, and hypothesized that *Cyrano* functions were at least partially determined through its unique relationship with *mir-7* ([@bib70]). Several lines of evidence support this hypothesis. (1) In addition to a conventional seed match ([Figure S5](#mmc1){ref-type="supplementary-material"}A and [Table S1](#mmc2){ref-type="supplementary-material"}), the prominently expressed long splice variant ([Figure 5](#fig5){ref-type="fig"}A) of *Oip5-AS1*/*Cyrano* ([@bib65]) possesses an almost complete binding site to *mir-7* in mouse ESCs ([Figure 5](#fig5){ref-type="fig"}B) and this binding site is conserved across vertebrates ([Figure 5](#fig5){ref-type="fig"}A and [@bib70]). (2) Similar to previous observations in mouse brain ([@bib81]) and HEK293 ([@bib38]), *Cyrano* or its human ortholog is bound by Argonaute in ESCs ([Figure 5](#fig5){ref-type="fig"}C), similar to the known *mir-7* target gene *Igf1R* ([Figure S5](#mmc1){ref-type="supplementary-material"}B) ([@bib30]). (3) *mir-7* is associated with differentiation in various cell types ([@bib16], [@bib39], [@bib54]). (4) *mir-7* is a documented Stat3 pathway antagonist ([@bib82]) and the LIF-Stat3-Nanog axis is required for mouse ESC self-renewal. (5) Similar to previous observations from Bartel and colleagues, we found that *mir-7* and *Cyrano* physically interact ([Figure 5](#fig5){ref-type="fig"}D), as observed for the *mir-7* target *Igf1R* ([@bib30]) ([Figure S5](#mmc1){ref-type="supplementary-material"}C), suggesting that this molecular interaction could be a mechanism for *Cyrano* regulation of *mir-7* function. Indeed, small RNA-seq data from ENCODE indicated that *mir-7* is expressed and localized similarly to *Cyrano* in ESCs ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Furthermore, nuclear enrichment of *mir-7* has been found in additional contexts including HEK293 and human carcinoma cell lines ([@bib44]), similar to that observed for *Cyrano* ([Figures 1](#fig1){ref-type="fig"}A, 1C, and [S1](#mmc1){ref-type="supplementary-material"}A--S1E).Figure 5*Cyrano* Restrains *mir-7* Activity to Support ESC Self-Renewal(A) Genome browser blots showing *Oip5-AS1*/*Cyrano* splice variants. Despite the presence of multiple splice variants of *Oip5-AS1*, the long variant containing the conserved *mir-7* binding site (gray box; segment of this region with the *mir-7* interaction site is expanded in B) is prominently expressed in human ESCs (top panel, GEO: [GSE41009](ncbi-geo:GSE41009){#intref0045}) and mouse ESCs (bottom panel, GEO: [GSE36799](ncbi-geo:GSE36799){#intref0050}). Blue box marks additional conventional *mir-7* seed sequence. Con denotes conservation: Vertebrate Multiz Alignment & Conservation; PE, paired-end RNA-seq; Cyr, *Cyrano*.(B) Near-complete *mir-7* sequence complementarity is observed in *Cyrano* sequenced from ESCs.(C) RNA immunoprecipitation indicates that *Cyrano* is bound by Ago2 in ESCs. Experiments were performed in triplicate with error bars representing SEM.(D) miRNA pull-down and qPCR indicates a physical interaction between *Cyrano* and *mir-*7. Experiments were performed in triplicate with error bars representing SEM.(E and F) The 3′ UTRs of *Itga9* and *Nanog* contain *mir-7* target sites (see [Figure S5](#mmc1){ref-type="supplementary-material"}; [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"} for further information on target sites).(G--N) Overexpression of *mir-7* (G) results in a decrease in *Itga9* (H) and *Nanog* levels (I), loss of ESC self-renewal maintenance (J), and increased cell death (K) in ESCs 2 days post transfection. Nuclei (blue, live; green, dead); Scale bar, 100 μm. qRT-PCR monitoring of *Cyrano* (L), *Itga9* (M), and *Nanog* (N) levels with *Cyrano* overexpression. Error bars for qRT-PCR expression analysis represent 95% CI.Data are from three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01. See also [Figure S5](#mmc1){ref-type="supplementary-material"}; [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}.

We then determined whether *mir-7* could affect ESC maintenance by downregulating key adhesion and self-renewal regulators. First, we used mirWalk ([@bib19]) ([Figure S5](#mmc1){ref-type="supplementary-material"}E and [Table S2](#mmc3){ref-type="supplementary-material"}), TargetScan ([@bib2], [@bib40], [@bib41]), and RNA22 ([@bib49]), and found that the 3′ UTR of the ESC-enriched integrin *Itga9* ([@bib52], [@bib62]) ([Figure 5](#fig5){ref-type="fig"}E) contains a strong 8mer *mir-7* seed sequence. Interestingly, examination of *Nanog*\'s 3′ UTR also revealed a 7mer-A1 *mir-7* seed match ([Figure 5](#fig5){ref-type="fig"}F). Second, we transfected ESCs with a *mir-7* mimic ([Figures 5](#fig5){ref-type="fig"}G, [S5](#mmc1){ref-type="supplementary-material"}F, and S5G) and observed a decrease in *Itga9* ([Figure 5](#fig5){ref-type="fig"}H) and *Nanog* levels ([Figure 5](#fig5){ref-type="fig"}I). Third, as the *mir-7-Nanog* interaction was based on a weaker prediction, we introduced the *mir-7* mimic along with a luciferase reporter plasmid constituting of the *Nanog* 3′ UTR together with a transfection control and observed inhibition of luciferase expression ([Figure S5](#mmc1){ref-type="supplementary-material"}H). Also, inhibition of *mir-7* resulted in increased *Nanog* levels ([Figure S5](#mmc1){ref-type="supplementary-material"}I). We also found that *Cyrano* levels decreased upon introduction of the *mir-7* mimic, suggesting that *mir-7* also regulates *Cyrano* in ESCs ([Figure S5](#mmc1){ref-type="supplementary-material"}J). Importantly, when we transfected ESCs with the *mir-7* mimic and monitored the ESC phenotype in LIF-containing medium, we observed a loss of ESC colony maintenance within 2 days of *mir-7* introduction ([Figure 5](#fig5){ref-type="fig"}J). This was accompanied by anomalies in cell and colony adhesion with numerous detached cells ([Figure 5](#fig5){ref-type="fig"}J) and increases in cell death ([Figure 5](#fig5){ref-type="fig"}K), similar to observations made upon *Cyrano* depletion. Finally, as *Itga9* and *Nanog* levels decreased upon *mir-7* overexpression as well as upon *Cyrano* depletion ([Figures S5](#mmc1){ref-type="supplementary-material"}K and [S4](#mmc1){ref-type="supplementary-material"}B--S4D), we hypothesized that *Itga9* and *Nanog* levels would increase with modulation of *Cyrano* levels and found that increased expression of *Cyrano* ([Figure 5](#fig5){ref-type="fig"}L) augmented their expression ([Figures 5](#fig5){ref-type="fig"}M and 5N). This suggests that *Cyrano* and *mir-7* act in opposition to one another in ESCs.

It is now well established that compared with culture in serum + LIF, mouse ESCs can be cultured more homogenously in the presence of GSK3 and MEK inhibitors (2i, [@bib79]). Due to the heterogeneity observed in serum + LIF, we also tested the effect of *Cyrano* depletion under conditions of more homogeneity. Under 2i conditions, *Nanog* expression is somewhat higher than that of growth conditions in serum-containing medium ([@bib1]), whereas *Cyrano*\'s levels remain unchanged ([Figure S6](#mmc1){ref-type="supplementary-material"}). To further delineate whether *Cyrano* functions upstream of *Nanog*, we examined the effect of *Cyrano* KD in ESCs under conditions of higher *Nanog* expression: (1) cells cultured in 2i and (2) *Nanog* overexpression. Similar to observations in serum-containing LIF medium, KD of *Cyrano* in 2i resulted primarily in a loss of self-renewal maintenance, and increased *Nanog* expression resulted in partial recovery of self-renewal capacity ([Figures 6](#fig6){ref-type="fig"}A--6D). This suggests that additional mechanisms of *Cyrano* action are functional in ESC maintenance. Delineation of *Cyrano* function can be further enhanced through single-cell analyses of ESC lines harboring endogenously encoded reporters and mutant alleles of *Cyrano* and putative direct and indirect targets.Figure 6Ability of Increased *Nanog* Expression to Rescue the *Cyrano* KD Phenotype(A and B) A reduction in alkaline phosphatase staining is observed in ESC colonies after *Cyrano* KD in 2i medium.(C and D) *Nanog* overexpression results in qualitative/partial rescue of *Cyrano* KD phenotype. n \> 120.Scale bar, 100 μm. Data are from three independent experiments and error bars represent SD. ^∗^p \< 0.05, ^∗∗^p \< 0.01. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Altogether, we provide evidence for *Cyrano*\'s role in cell survival and colony maintenance in self-renewing ESCs. Furthermore, our results provide evidence for one direct mechanism by which *Cyrano* functions, namely the existence of a negative-feedback loop between *Cyrano* and *mir-7* (see Graphical Abstract), to support the maintenance of ESC self-renewal through factors including *Nanog* and *Itga9* that sustain key properties of pluripotent cells.

Discussion {#sec3}
==========

Of the nearly 9,000 known lncRNAs ([@bib18], [@bib25], [@bib26]), the mechanism of action is understood for only a small fraction. We have described a previously undefined role for *Cyrano* in the maintenance of the self-renewing state of mammalian pluripotent cells, a model cell type for establishing mechanisms of action relevant to early development and regenerative medicine.

In our characterization of *Cyrano* function, we show that depletion of *Cyrano* results in disarray in the pluripotent gene expression signature and defects in self-renewal maintenance. Driving this is aberrations in colony survival and preservation, which requires maintenance of cellular adhesion and signaling, as well as the decrease in *Nanog* expression, which itself is required for cell growth and apoptosis avoidance in ESCs ([@bib11]). Furthermore, it is well established that *Nanog* function has far-reaching implications in the repression of negative regulators of the ESC state, such as *Dkk1* and *Gata6* ([@bib47], [@bib64]). Mining gene expression data produced in a recent shRNA screen for lncRNAs that regulate pluripotency further supports *Cyrano*\'s key role ([@bib45]).

Misregulation and aberrant expression of lncRNAs are increasingly associated with disease states ([@bib73], [@bib6], [@bib21]). Similar signaling pathways (e.g., Jak-Stat, PI3K/AKT) and transcription factors (e.g., Myc, Stat3) activities support stem cell growth and survival as well as tumorigenesis ([@bib35]). As *Cyrano* displays particularly high expression in ENCODE cancer cell lines, a priority will be to determine the requirement of *Cyrano* in tumor cell survival and cellular reprogramming to a malignant state. Indeed, similar to our findings in ESCs, *Cyrano* supports glioma cell proliferation in addition to cell migration and tumorigenesis ([@bib28]).

Complex relationships exist between miRNAs and lncRNAs in transcriptional, post-transcriptional, and translational regulatory processes. Previous studies have shown that lncRNAs can function as miRNA precursors and miRNA targets, or compete as decoys/sponges/competing endogenous RNAs to prevent inhibition of mRNA targets ([@bib29], [@bib55]). In the context of skeletal muscle differentiation, *H19* antagonizes *let-7*, releasing the repression of *let-7* targets such as *HMGA2* ([@bib31]). Similarly, if *Cyrano* has a negative influence on *mir-7* function, it would be expected that depletion of *Cyrano* would free *mir-7* to repress its targets, while overexpression of *Cyrano* would boost *mir-7* target-transcript levels, consistent with our observations.

Moreover, the combination of multiple sites for binding to *Cyrano*, including the unique ultra-conserved binding site, along with the intermediate expression of *mir-7* in ESCs ([@bib66]), suggests that it is feasible for *Cyrano* to attenuate *mir-7* activity to sustain self-renewal. This is particularly relevant for supporting the maintenance of expression of targets such as *Nanog*, which display some heterogeneity in expression in ESCs ([@bib1], [@bib64]). While *Nanog* transcripts range from 0 to 500 mRNA molecules per ESC in normal culture conditions, a fraction of pluripotent cells exhibit low *Nanog* expression in the range of \<25 molecules/cell ([@bib1]). One hypothesis is that *Cyrano* is one factor that presents a barrier to lineage commitment in conditions of suboptimal fluctuations in *Nanog* levels. Additionally or alternatively, *Cyrano* may also directly repress lineage specification factors. Further studies may reveal mechanisms behind the molecular interplay between *Cyrano* and its interacting RNAs at the single-molecule and single-cell levels.

Based on our and previously available data, we postulate that regulating RNAs and proteins through interactions is a prominent role of the 8.2-kb *Cyrano* molecule. Indeed, the ortholog *OIP5-AS1* has been found to bind 37 RNA binding proteins (RBPs) ([@bib42]), and a recent report provided further evidence for *Cyrano*\'s interaction with other RNAs and highlighted the capacity for *Cyrano* to function as a sponge of RBPs from mRNAs ([@bib37]). Overall, our observations along with other emerging data on *Cyrano*, which in various systems include anti-proliferative functions and roles in organogenesis/embryonic development, are strongly indicative of complex biological function, which clearly warrants further study.

Experimental Procedures {#sec4}
=======================

Cell Culture and RNAi {#sec4.1}
---------------------

Mouse R1 (XY, [@bib53]) ESCs were maintained in complete medium supplemented with LIF on gelatin-coated dishes. Mouse ES2-1 (XX, [@bib61]) were maintained in complete medium with LIF on feeders or gelatin-coated dishes. Embryoid body differentiation was carried out on low adherent dishes under LIF withdrawal conditions.

RNA Extraction and qRT-PCR {#sec4.2}
--------------------------

Total RNA was isolated using the RNeasy Mini Kit (Qiagen) or the Quick-RNA MiniPrep Kit (Zymo), followed by DNase treatment (Ambion) and reverse transcription using the iScript reagent (Bio-Rad). qRT-PCR for lncRNA and mRNA transcripts was performed using primers listed in [Table S3](#mmc4){ref-type="supplementary-material"} with the SsoFast Evagreen Supermix (Bio-Rad) or Taqman Assays (Applied Biosystems).

miRNAs were extracted with the Quick-RNA MiniPrep Kit (Zymo) and reverse transcription carried out with the TaqMan MicroRNA Reverse Transcription Kit. *miR-7* and the *U6* control were amplified using the TaqMan Universal Master Mix II, no UNG and TaqMan microRNA assays for *mmu-miR-7a-5p* and *U6*, respectively.

Data were analyzed based on the 2^−ΔΔCt^, after log transformation, mean centering, and autoscaling ([@bib76]). For these and other quantitative data, experiments were carried out in at least three independent replicates and unpaired, two-tailed Student\'s t-tests used to determine statistical significance (^∗∗^p \< 0.01, ^∗^p \< 0.05, ^†^p \< 0.1 in figures).

Alkaline Phosphatase Assay {#sec4.3}
--------------------------

Alkaline phosphatase activity was detected using a leukocyte alkaline phosphatase staining kit (Sigma), and the effect of *Cyrano* KD assessed on day 3 post-transfection.

smFISH {#sec4.4}
------

A pool of 36 FISH probes for *Cyrano* was used for hybridization (Biosearch Technologies) for cells cultured on coverslips for approximately 24--30 hr. After fixing with 4% paraformaldehyde (PFA) and permeabilization, cells were hybridized in 100 mg/mL dextran sulfate, 1% formamide, and 2× saline sodium citrate overnight at 37°C.

Transcriptomics {#sec4.5}
---------------

Libraries for RNA-seq were prepared from total RNA with a modified dUTP strand-specific method ([@bib83]). RNA-seq reads were aligned to the mm9 mouse genome using TopHat ([@bib69]) and reads per gene were counted using HTSeq-count ([@bib4]). Normalized bedgraphs were generated for the UCSC genome browser using bedtools ([@bib57]). Differential expression between NTC and shRNA KD was performed using edgeR ([@bib60]) after removing genes with fewer than 20 reads, mapping to them across all replicates. Expression changes were visualized using ggplot2 ([@bib75]).

Publicly available microarray data (GEO: [GSE18290](ncbi-geo:GSE18290){#intref0010}) ([@bib77]) of 1-cell, 2-cell, 4-cell, 8-cell, morula, and blastocyst embryos were used to examine the expression of *Cyrano*, Airn, and H19 lncRNAs. Publicly available data (GEO: [GSE45719](ncbi-geo:GSE45719){#intref0015}, [@bib17]) were used for single-cell RNA-seq analysis of *Cyrano* (1700020I14Rik) expression in preimplantation embryos.

Publicly available paired-end RNA-seq data (GEO: [GSE36799](ncbi-geo:GSE36799){#intref0020}, [GSE41009](ncbi-geo:GSE41009){#intref0025}; [@bib65]) were used to examine expression of *Cyrano* splice variants in mouse and human ESCs.

RNA Immunoprecipitation and miRNA Target Isolation {#sec4.6}
--------------------------------------------------

Coimmunoprecipitation of Argonaute-bound RNAs was performed generally as previously described ([@bib51]). Ago2 antibody (04-642, Millipore) or immunoglobulin G control was coupled to protein A/G magnetic beads (Thermo Fisher) and incubated with cellular lysate prepared from approximately 1.0 × 10^7^ cells previously crosslinked with 0.3% formaldehyde. Immunoprecipitation was carried out overnight at 4°C with gentle rotation followed by extensive washes. RNA was eluted in the presence of proteinase K and incubated at 65°C for 2 hr to reverse crosslinks. RNA was purified using the RNA Clean & Concentrator Kit (Zymo) followed by reverse transcription (iScript, Bio-Rad) for use in qPCR.

Cells for miRNA pull-down were transfected with biotin-tagged *mir-7* at a concentration of 50 nM and harvested approximately 30 hr post transfection. Cleared cellular lysate was incubated with streptavidin-magnetic beads preblocked with RNase-free BSA and yeast tRNA for 1 hr at 4°C. After washing, RNA was isolated with TRIzol, followed by reverse transcription (iScript) for use in qPCR.

Western Blot Analysis and Immunofluorescence {#sec4.7}
--------------------------------------------

Antibodies were used for lamin A/C (E-1, sc-376248, Santa Cruz Biotechnology), Oct4 (C-10, sc-5279, Santa Cruz), Nanog (A300-397A, Bethyl Laboratories; \#8822, Cell Signaling Technologies), E-cadherin (13-1900, Zymed), and β-actin (ab8226, Abcam) on cell extracts prepared using a modified RIPA buffer or fixed for immunofluorescence experiments with 4% PFA.

miRNA Binding Site Prediction and Luciferase Assays {#sec4.8}
---------------------------------------------------

miRNA binding sites for *Itga9* and *Nanog* were predicted using miRWalk ([@bib19]), TargetScan ([@bib2], [@bib40], [@bib41]), and RNA22 ([@bib49]). Cells were cotransfected in 24-well plates using Lipofectamine 3000 (Thermo Fisher) for Dual-Luciferase Reporter Assays (Promega) according to the manufacturer\'s protocol. miRNA mimics (50 nM, Dharmacon) were introduced along with 50 ng of the firefly luciferase vector pGL3 containing the *Nanog* 3′ UTR (Luc-Nanog-3′ UTR was a gift from Lin He, Addgene plasmid \#63893) ([@bib14]) and 5 ng of the control Renilla luciferase vector, pRL-TK (Promega). Firefly luciferase and Renilla luciferase activities were consecutively measured 48 hr post transfection.
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